Novak Djokovic said he had no regrets about missing tournaments at Indian Wells and Miami due to his Covid-19 vaccination status but hoped that he would be allowed into the United States later this year for the US Open.

OTTAWA, March 24 (Reuters) - The United States and Canada pledged to work together on several issues, including migration, defense and security, the two countries said on Friday after a meeting between U.S.

President Joe Biden and Canadian Prime Minister Justin Trudeau.

military carried out air strikes against Iran-backed forces in retaliation for an attack that killed an American contractor and wounded five U.S. OTTAWA, March 24 (Reuters) - U.S.

President Joe Biden on Friday said the United States is prepared to "act forcefully" to protect Americans, commenting after the U.S.

"The theater forces will maintain a high state of alert at all times and take all necessary measures to resolutely safeguard national sovereignty and security and peace and stability in the South China Sea," said Tian Junli, a spokesman for China's Southern Theatre Command.

The United States has been shoring up alliances in the Asia-Pacific seeking to counter China's assertiveness in the South China Sea and the Taiwan Strait, as Beijing seeks to advance its territorial claims.

(Reporting by Andrea Shalal; writing by Jasper Ward; editing by Tim Ahmann) seek conflict with Iran, but be prepared for us to act forcefully to protect our people," Biden told reporters during an official visit to Canada. "Make no mistake: the United States does not ...

Canada and the United States also acknowledged "the serious long-term challenge to the international order posed by the People's Republic of China, including disruptive actions such as economic coercion, non-market policies and practices, and human rights abuses," the two countries said in a joint statement.

March 22 (Reuters) - Regeneron Pharmaceuticals Inc said on Wednesday the U.S.

Food and Drug Administration had approved the expanded use of its drug in children aged 5 to 11 years to treat an ultra-rare disease that causes high cholesterol.

The drug, Evkeeza, was approved in February 2021 as an additional treatment with other lipid-lowering therapies for patients aged 12 years and above with homozygous familial hypercholesterolemia (HoFH).